Clinical Trials Directory

Trials / Completed

CompletedNCT00000355

Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

Effects of Buprenophine and Naloxone in Opiate Addicts

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 59 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine

Timeline

Start date
1994-11-01
Primary completion
1996-01-01
Completion
1996-03-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000355. Inclusion in this directory is not an endorsement.